Advanced

Immunohistochemical Expression of CD23 and CD40 May Identify Prognostically Favorable Subgroups of Diffuse Large B-cell Lymphoma: A Nordic Lymphoma Group Study.

Linderoth, Johan LU ; Jerkeman, Mats LU ; Cavallin-Ståhl, Eva LU ; Kvaløy, Stein and Torlakovic, Emina (2003) In Clinical Cancer Research 9(2). p.722-728
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Clinical Cancer Research
volume
9
issue
2
pages
722 - 728
publisher
American Association for Cancer Research
external identifiers
  • wos:000180840200027
  • pmid:12576441
  • scopus:0037314744
ISSN
1078-0432
language
English
LU publication?
yes
id
826a9650-47cd-4ae3-964d-756c0f8d8384 (old id 112338)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12576441&dopt=Abstract
http://clincancerres.aacrjournals.org/content/9/2/722.full
date added to LUP
2007-07-19 08:49:25
date last changed
2018-09-02 03:30:00
@article{826a9650-47cd-4ae3-964d-756c0f8d8384,
  author       = {Linderoth, Johan and Jerkeman, Mats and Cavallin-Ståhl, Eva and Kvaløy, Stein and Torlakovic, Emina},
  issn         = {1078-0432},
  language     = {eng},
  number       = {2},
  pages        = {722--728},
  publisher    = {American Association for Cancer Research},
  series       = {Clinical Cancer Research},
  title        = {Immunohistochemical Expression of CD23 and CD40 May Identify Prognostically Favorable Subgroups of Diffuse Large B-cell Lymphoma: A Nordic Lymphoma Group Study.},
  volume       = {9},
  year         = {2003},
}